BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choi J, Choi J, Kim M, Lim JS, Park MS, Kim JH, Chung YE. Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent. J Magn Reson Imaging 2010;31:571-8. [DOI: 10.1002/jmri.22076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL. Diagnostic Challenges and Pitfalls in MR Imaging with Hepatocyte-specific Contrast Agents. RadioGraphics 2011;31:1547-68. [DOI: 10.1148/rg.316115528] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 7.7] [Reference Citation Analysis]
2 Costa EA, Cunha GM, Smorodinsky E, Cruite I, Tang A, Marks RM, Clark L, Wolfson T, Gamst A, Sicklick JK, Hemming A, Peterson MR, Middleton MS, Sirlin CB. Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard. Radiology 2015;276:775-86. [PMID: 25875972 DOI: 10.1148/radiol.2015142069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
3 Tran PV, Jhaveri KS. Comparison of high spatial resolution respiratory triggered inversion recovery-prepared spoiled gradient echo sequence with standard breathhold T1 sequence MRI of the liver using gadoxetic acid. J Magn Reson Imaging. 2013;37:700-706. [PMID: 23335396 DOI: 10.1002/jmri.23864] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
4 Brismar TB, Kartalis N, Kylander C, Albiin N. MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine. Eur Radiol 2012;22:633-41. [PMID: 21953376 DOI: 10.1007/s00330-011-2288-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
5 Renzulli M, Clemente A, Ierardi AM, Pettinari I, Tovoli F, Brocchi S, Peta G, Cappabianca S, Carrafiello G, Golfieri R. Imaging of Colorectal Liver Metastases: New Developments and Pending Issues. Cancers (Basel) 2020;12:E151. [PMID: 31936319 DOI: 10.3390/cancers12010151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
6 Bastati-Huber N, Prosch H, Baroud S, Magnaldi S, Schima W, Ba-Ssalamah A. [New developments in MRI of the liver]. Radiologe 2011;51:680-7. [PMID: 21809147 DOI: 10.1007/s00117-010-2126-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Granata V, Catalano O, Fusco R, Tatangelo F, Rega D, Nasti G, Avallone A, Piccirillo M, Izzo F, Petrillo A. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA “uptake” on the hepatobiliary phase of MR imaging. Abdom Imaging 2015;40:2364-71. [DOI: 10.1007/s00261-015-0488-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
8 Jeong HT, Kim MJ, Park MS, Choi JY, Choi JS, Kim KS, Choi GH, Shin SJ. Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging. J Magn Reson Imaging. 2012;35:635-643. [PMID: 22095933 DOI: 10.1002/jmri.22880] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
9 Zhang L, Yu X, Huo L, Lu L, Pan X, Jia N, Fan X, Morana G, Grazioli L, Schneider G. Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI. Eur Radiol 2019;29:5205-16. [PMID: 30915560 DOI: 10.1007/s00330-019-06110-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Akin O, Brennan SB, Dershaw DD, Ginsberg MS, Gollub MJ, Schöder H, Panicek DM, Hricak H. Advances in oncologic imaging: Update on 5 Common Cancers. CA: A Cancer Journal for Clinicians 2012;62:364-93. [DOI: 10.3322/caac.21156] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
11 Kolbe AB, Podberesky DJ, Zhang B, Towbin AJ. The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion. Pediatr Radiol 2015;45:354-65. [PMID: 25246096 DOI: 10.1007/s00247-014-3160-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
12 Matos AP, Altun E, Ramalho M, Velloni F, Alobaidy M, Semelka RC. An overview of imaging techniques for liver metastases management. Expert Review of Gastroenterology & Hepatology 2015;9:1561-76. [DOI: 10.1586/17474124.2015.1092873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
13 Lee HJ, Lee CH, Kim JW, Park YS, Lee J, Kim KA. Use of hepatobiliary phase images in Gd-EOB-DTPA-enhanced MRI of breast cancer hepatic metastasis to predict response to chemotherapy. Clin Imaging 2017;43:127-31. [PMID: 28314197 DOI: 10.1016/j.clinimag.2017.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Ulloa JL, Stahl S, Yates J, Woodhouse N, Kenna JG, Jones HB, Waterton JC, Hockings PD. Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition. NMR Biomed 2013;26:1258-70. [PMID: 23564602 DOI: 10.1002/nbm.2946] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
15 Scali EP, Walshe T, Tiwari HA, Harris AC, Chang SD. A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine. Can Assoc Radiol J 2017;68:293-307. [PMID: 28583364 DOI: 10.1016/j.carj.2016.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Ha S, Lee CH, Kim BH, Park YS, Lee J, Choi JW, Kim KA, Park CM. Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the “target sign” a common finding? Magn Reson Imaging. 2012;30:1083-1090. [PMID: 22578929 DOI: 10.1016/j.mri.2012.03.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]